Eutopic overexpression of vasopressin V1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 12, 2002, Pages 5706-5713

  Mune, Tomoatsu ^a   Murase, Hiroshi ^b   Yamakita, Noriyoshi ^c   Fukuda, Tetsuya ^d   Murayama, Masanori ^e   Miura, Atsushi ^a   Suwa, Tetsuya ^a   Hanafusa, Junko ^a   Daido, Hisashi ^a   Morita, Hiroyuki ^a   Yasuda, Keigo ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Daiyukai General Hospital   (Japan)

^c Matsunami General Hospital   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; HYDROCORTISONE; MESSENGER RNA; UNCLASSIFIED DRUG; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V1A RECEPTOR; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V3 RECEPTOR;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORTICOTROPIN RELEASE; CUSHING SYNDROME; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADRENAL GLAND DISEASES; ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; ARGININE VASOPRESSIN; CUSHING SYNDROME; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; PHENOTYPE; PROTEIN ISOFORMS; RECEPTORS, VASOPRESSIN; RNA, MESSENGER;

EID: 0036920896     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020067     Document Type: Article

References (42)

1. Payet N, Lehoux JG 1980 A comparative study of the role of vasopressin and ACTH in the regulation of growth and function of rat adrenal gland. J Steroid Biochem 12:461-467
2. Guillon G, Trueba M, Joubert D, Grazzini E, Chouinard L, Cote M, Payet MD, Manzoni O, Barberis C, Robert M, Gallo-Payet N 1995 Vasopressin stimulates steroid secretion in human adrenal glands: Comparison with angiotensin-II effect. Endocrinology 136:1285-1295
3. 2 receptor and possible link to nephrogenic diabetes insipidus. Nature 357:336-339
4. Gillies GE, Linton EA, Lowry PJ 1982 Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin. Nature 299:355-357
5. 1b vasopressin receptor. J Biol Chem 269:27088-27092
6. 1 receptors. J Clin Endocrinol Metab 76:1522-1528
7. Ang VTY, Jenkins JS 1984 Neurohypophysial hormones in the adrenal medulla. J Clin Endocrinol Metab 58:688-691
8. Lacroix A, N'Diaye N, Tremblay J, Hamet P 2001 Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22:75-110
9. 1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clin Endocrinol 48:403-409
10. Yamakita N, Murai T, Ito Y, Miura K, Ikeda T, Miyamoto K, Onami S, Yoshida T 1997 Adrenocorticotropin-indepencient macronodular adrenocortical hyperplasia associated with multiple colon adenomas/carcinomas which showed a point mutation in the APC gene. Intern Med 36:536-542
11. Morioka M, Ohashi Y, Watanabe H, Komatsu F, Jin TX, Suyama B, Tanaka H 1997 ACTH-independent macronodular adrenocortical hyperplasia (AIMAH): Report of two cases and the analysis of steroidogenic activity in adrenal nodules. Endocr J 44:65-72
12. Suwa T, Mune T, Morita H, Daido H, Saio M, Yasuda K 2000 Role of rat adrenal antioxidant defense systems in the aldosterone turn-off phenomenon. J Steroid Biochem Mol Biol 73:71-78
13. 1a vasopressin receptor gene. Genomics 31:327-334
14. Mohr E, Hillers M, Ivell R, Haulica ID, Richter D 1985 Expression of the vasopressin and oxytocin genes in human hypothalami. FEBS Lett 193:12-16
15. Tso JY, Sun XH, Kao TH, Reece KS, Wu R 1985 Isolation and characterization of rat and human glyceraldehyde 3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502
16. Mune T, White PC 1996 Apparent mineralocorticoid excess: Genotype is correlated with biochemical phenotype. Hypertension 27:1193-1199
17. Seibold A, Brabet P, Rosenthal W, Birnbaumer M 1992 Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet 51:1078-1083
18. 3) gene. Gene 241:57-64
19. Kirschner MA, Powell DR, Lipsett MB 1964 Cushing's syndrome: Nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor. J Clin Endocrinol Metab 24:947-955
20. Malchoff CD, Rosa J, DeBold CR, Kozoi RA, Ramsby GR, Page DL, Malchoff DM, Orth DN 1989 Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: An unusual cause of Cushing's syndrome. J Clin Endocrinol Metab 68:855-860
21. Aiba M, Hirayama A, Iri H, Ito Y, Fujimoto Y, Mabuchi G, Murai M, Tazaki H, Maruyama H, Saruta T, Suda T, Demura H 1991 Adrenocorticotroplc hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Am J Clin Pathol 96:334-340
22. Sasano H, Suzuki T, Nagura H 1994 ACTH-independent macronodular adrenocortical hyperplasia: Immunohistochemical and in situ hybridization studies of steroidogerdc enzymes. Mod Pathol 7:215-219
23. Ohashi A, Yamada Y, Sakaguchi K, Inoue T, Kubo M, Fushimi H 2001 A natural history of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) from preclinical to clinically overt Cushing's syndrome. Endocr J 48:677-683
24. 1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Clin Endocrinol Metab 83:2029-2035
25. 1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab 82:2414-2422
26. Bourdeau I, D'Amour P, Hamet P, Boutin JM, Lacroix A 2001 Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome. J Clin Endocrinol Metab 86:5534-5540
27. Findlay JC, Sheeler LR, Engeland WC, Aron DC 1993 Familial adrenocorticotropin-independent Cushing's syndrome with bilateral maeronodular adrenal hyperplasia. J Clin Endocrinol Metab 76:189-191
28. Lacroix A, Bolte E, Tremblay J, Dupre J, Poitras P, Foumier H, Garon J, Garrel D, Bayard F, Taillefer R, Flanagan RJ, Hamet P 1992 Gastric inhibitory polypeptide-dependent cortisol hypersecrehon - A new cause of Cushing's syndrome. N Engl J Med 327:974-980
29. Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM, Mahoudeau J 1992 Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 327:981-986
30. Lebrethon MC, Avallet O, Reznik Y, Archambeaud F, Combes J, Usdin TB, Narboni G, Mahoudeau J, Saez JM 1998 Food-dependent Cushing's syndrome: Characterization and functional role of gastric inhibitory polypeptide receptor in the adrenals of three patients. J Clin Endocrinol Metab 83:4514-4519
31. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P 1997 Propranolol therapy for ectopic β-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 337:1429-1434
32. Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P, Lacroix A 2000 Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J Clin Endocrinol Metab 85:3531-3536
33. Lacroix A, Hamet P, Boutin JM 1999 Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome. N Engl J Med 341:1577-1581
34. Demura R, Demura H, Nunokawa T, Baba H, Miura K 1972 Responses of plasma ACTH, GH, LH and 11-hydroxyeorticosteroids to various stimuli in patients with Cushing's syndrome. J Clin Endocrinol Metab 34:852-859
35. Perraudin V, Delarue C, Keyzer YD, Bertagna X, Kuhn JM, Contesse V, Clauser E, Vaudry H 1995 Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: In vivo and in vitro studies. J Clin Endocrinol Metab 80:2661-2667
36. 1a vasopressm receptors by glucocorticoids. Am J Physiol 263:E1054-E1062
37. Iwasaki Y, Oiso Y, Saito H, Majzoub JA 1997 Positive and negative regulation of the rat vasopressin gene promoter. Endocrinology 138:5266-5274
38. Mune T, Morita H, Suzuki T, Takahashi Y, Isomura Y, Tanahashi T, Daido H, Yamakita N, Deguchi T, Sasano H, White PC, Yasuda K, Role of local 11β-hydroxysteroid dehydrogenase type 2 (HSD11B2) expression in determining the phenotype of adrenal adenomas. J Clin Endocrinol Metab, in press
39. Sasano H 1994 Localization of steroidogenic enzymes in adrenal cortex and its disorders. Endocr J 41:471-482
40. Payet N, Deziel Y, Lehoux JG 1984 Vasopressin: A potent growth factor in adrenal glomerulosa cells in culture. J Steroid Bioehem 20:449-454
41. Mazzocchi G, Markowska A, Malendowicz LK, Musajo F, Meneghelli V, Nussdorfer GG 1993 Evidence that endogenous arginine-vasopressin (AVP) is involved in the maintenance of the growth and steroidogenic capacity of rat adrenal zona glomerulosa. J Steroid Biochem Mol Biol 45:251-256
42. Gallo-Payet N, Guillon G 1998 Regulation of adrenocortical function by vasopressin. Horm Metab Res 30:360-367